Corporate advisers should discuss transgender support

In light of BBC investigation

Adam Saville
clock • 1 min read

In some parts of UK, transgender patients are waiting as long as two years to be seen by NHS

In light of a recent BBC investigation revealing that transgender patients are choosing self-medicate with hormones due to long NHS waits, Aviva's medical director has urged group risk intermediaries and employee benefits consultants to discuss the issue with corporate clients. Dr Doug Wright, medical director, health and protection, at Aviva said: "The investigation from the BBC Victoria Derbyshire Show demonstrates the length of time that transgender people are needing to wait and the tough decisions that they are making, such as self-medicating using unregulated hormones bought online...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Group Protection

Employers 'misjudge' which benefits workers prioritise

Employers 'misjudge' which benefits workers prioritise

Canada Life research

Jaskeet Briah
clock 19 June 2025 • 2 min read
L&G paid out £347m in group protection claims in 2024

L&G paid out £347m in group protection claims in 2024

Paid out just shy of £1m every day

Jenna Brown
clock 19 June 2025 • 3 min read
Benenden Health adds heart rhythm measurements to offering

Benenden Health adds heart rhythm measurements to offering

Partnership with FibriCheck

Jaskeet Briah
clock 06 June 2025 • 2 min read